SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.490-3.6%2:46 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BulbaMan who wrote (10)6/25/1997 4:36:00 PM
From: Tiger   of 3578
 
NEW YORK (Dow Jones)--Geron Corp. (GERN) shares fell 12.3%, which may have been caused by the sale of shares by limited partners of a venture capital firm that had been one of the original investors in the company, according to Chief Financial Officer David Greenwood.

The firm, which Greenwood declined to identify, recently completed a distribution of stock to its limited partners. He said that such distributions sometimes result in the sale of stock.

Greenwood said that the company has no other news to account for the decline in its shares.

Geron's shares slipped 1, or 12.3%, to 7 1/8 on Nasdaq volume of 111,700. Average volume is 33,200.

(END) DOW JONES NEWS 06-25-97

4:08 PM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext